{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:27:33Z","timestamp":1760866053648,"version":"build-2065373602"},"reference-count":22,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[1980,5,1]],"date-time":"1980-05-01T00:00:00Z","timestamp":325987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Parenter Enteral Nutr"],"published-print":{"date-parts":[[1980,5]]},"abstract":"<jats:p>The urinary 3\u2010methylhistidine (3\u2010MH) and creatinine excretion were measured serially in two patients on total parenteral nutrition for 201 and 225 days, respectively. Variations in excretion were related to clinical events, such as sepsis; 3\u2010MH excretion and the 3\u2010MH: creatinine ratio were raised in association with some episodes of infection, but not all. It is concluded that, although infection is often associated with increased myofibrillar protein breakdown, this is not always the case. It is suggested that in susceptible patients a high 3\u2010MH:creatinine ratio may indicate occult infection not detectable by other means.<\/jats:p>","DOI":"10.1177\/014860718000400308","type":"journal-article","created":{"date-parts":[[2017,1,15]],"date-time":"2017-01-15T08:51:11Z","timestamp":1484470271000},"page":"286-289","source":"Crossref","is-referenced-by-count":5,"title":["Urinary 3 \u2010Methylhistidine: Creatinine Ratio in Patients on Long\u2010Term Parenteral Nutrition"],"prefix":"10.1002","volume":"4","author":[{"given":"Peter","family":"Milewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles","family":"Irving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[1980,5]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1050361"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(67)90229-X"},{"key":"e_1_2_1_4_1","first-page":"3592","article-title":"Metabolism of administered 3\u2010methylhistidine. Lack of t(RNA) charging and quantitative excretion as 3\u2010methylhistidine and its N\u2010acetyl derivative.","volume":"247","author":"Young VR","year":"1972","journal-title":"J Biol Chem"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(75)90084-0"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj0740247"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/ajcn\/31.9.1608","article-title":"Urinary excretion of N'\u2010methylhistidine (3\u2010methylhistidine): a tool to study metabolic responses in relation to nutrient and hormonal studies in health and disease of man.","volume":"31","author":"Munro HN","year":"1978","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0560341"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/jn\/85.4.419","article-title":"Excretion of histidine and histidine derivatives by human subjects ingesting protein from different sources","volume":"85","author":"Block WD","year":"1965","journal-title":"J Nutr"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(78)90018-5"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(73)90257-6"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(73)90348-2"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800650922"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/ajcn\/28.2.110","article-title":"Urinary amino acid excretion during experimentally induced sandfly fever in man.","volume":"28","author":"Wannemacher RW","year":"1975","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/ajcn\/30.8.1269","article-title":"Key role of various individual amino acids in host response to infection","volume":"30","author":"Wannemacher RW","year":"1977","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/ajcn\/30.8.1349","article-title":"Muscle protein catabolism in the septic patient as measured by 3\u2010methylhistidine excretion","volume":"30","author":"Long CL","year":"1977","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_1_17_1","first-page":"527","article-title":"Muscle protein catabolism after injury in man, as measured by urinary excretion of 3\u2010methylhistidine.","volume":"52","author":"Williamson DH","year":"1977","journal-title":"Clin Sci Mol Med"},{"key":"e_1_2_1_18_1","first-page":"471","article-title":"Comparison of human myofibrillar protein catabolic rate derived from 3\u2010methylhistidine excretion with synthetic rate from muscle biopsies during L\u2010[15 N] lysine infusion.","volume":"54","author":"McKeran RO","year":"1978","journal-title":"Clin Sci Mol Med"},{"first-page":"192","volume-title":"Human Growth","author":"Greystone JE","key":"e_1_2_1_19_1"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1079\/BJN19790005"},{"key":"e_1_2_1_21_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/ajcp\/35.1_ts.83","article-title":"Determination of creatinine by means of automatic chemical analysis","volume":"35","author":"Chasson AL","year":"1961","journal-title":"Am J Chem Pathol"},{"key":"e_1_2_1_22_1","first-page":"62","article-title":"Evaluation of an automated nitrogen analyzer in the clinical laboratory.","volume":"4","author":"Holbrook IB","year":"1979","journal-title":"Br J Clin Equip"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1520503"}],"container-title":["Journal of Parenteral and Enteral Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/014860718000400308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T16:41:55Z","timestamp":1760632915000},"score":1,"resource":{"primary":{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/10.1177\/014860718000400308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1980,5]]}},"alternative-id":["10.1177\/014860718000400308"],"URL":"https:\/\/doi.org\/10.1177\/014860718000400308","archive":["Portico"],"relation":{},"ISSN":["0148-6071","1941-2444"],"issn-type":[{"type":"print","value":"0148-6071"},{"type":"electronic","value":"1941-2444"}],"subject":[],"published":{"date-parts":[[1980,5]]}}}